Key Market Indicators
The importation of insulin in Iran is projected to surge to approximately $233 million by 2028, up from $189 million in 2023. This marks an annual growth rate of 3.2%. Since 2003, the demand for insulin in Iran has seen a steady increase, averaging a 6% rise each year. The continual growth underscores the escalating need for diabetes management solutions in the country. As the healthcare sector evolves, this upward trend in insulin imports is expected to persist, reflecting broader global health challenges and the increasing prevalence of diabetes.
